REVERSIBLE INHIBITION OF LYMPHOKINE-ACTIVATED KILLER CELL-ACTIVITY BY LIPOXYGENASE-PATHWAY INHIBITORS

被引:14
作者
SIBBITT, WL
IMIR, T
BANKHURST, AD
机构
关键词
D O I
10.1002/ijc.2910380411
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:517 / 521
页数:5
相关论文
共 27 条
[1]  
BANKHURST AD, 1982, J CLIN LAB IMMUNOL, V7, P85
[2]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[3]  
FARRAM E, 1983, J IMMUNOL, V130, P1252
[4]  
GRIMM EA, 1982, J EXP MED, V155, P823
[5]  
HANNA N, 1981, J IMMUNOL, V127, P1754
[6]  
HATTORI T, 1983, J IMMUNOL, V131, P662
[7]   NATURAL KILLER CELLS AS ANTI-TUMOR EFFECTOR-CELLS [J].
HERBERMAN, RB ;
HOLDEN, HT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1979, 62 (03) :441-445
[8]   PHOSPHOLIPID METHYLATION AND PHOSPHOLIPASE-A2 ACTIVATION IN CYTO-TOXICITY BY HUMAN NATURAL-KILLER CELLS [J].
HOFFMAN, T ;
HIRATA, F ;
BOUGNOUX, P ;
FRASER, BA ;
GOLDFARB, RH ;
HERBERMAN, RB ;
AXELROD, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (06) :3839-3843
[9]   GENERATION OF NATURAL-KILLER CELLS AND LYMPHOKINE-ACTIVATED KILLER CELLS IN HUMAN AB SERUM OR FETAL BOVINE SERUM [J].
IMIR, T ;
GIBBS, DL ;
SIBBITT, WL ;
BANKHURST, AD .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1985, 36 (03) :289-296
[10]  
KARIBAYASHI K, 1981, J IMMUNOL, V126, P2321